HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...

name": "GPT - Billboard - Slot Inline - Content - Labeled - No Desktop", "component ... Human Immunodeficiency Virus, or HIV, swept through the nation in the mid-'80s, claiming the lives ...

The sweeping cuts in foreign aid announced Wednesday will slash HIV treatment, prevention and research, health services to treat malaria, and care for new mothers and their babies, among other ...

Wistar scientists have labeled this new approach "NuKES": Natural Killer Enhancement Strategy. Led by Luis J. Montaner, D.V.M., D.Phil., Wistar Executive Vice President and director of the HIV ...

cells to target and kill the HIV-positive cells that allow the virus to persist. Wistar scientists have labeled this this new approach “NuKES”: Natural Killer Enhancement Strategy. NK cells ...

The research found 1,519 new HIV diagnoses in 2022, mostly among men, of which 495 were labeled as AIDS. The highest rate of new cases is in Asunción (57.21%), followed by the departments of ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference ...